Aytu BioPharma (NASDAQ:AYTU) Shares Pass Below 50 Day Moving Average – Time to Sell?

Aytu BioPharma, Inc. (NASDAQ:AYTU)’s share price passed below its fifty day moving average during trading on Wednesday . The stock has a fifty day moving average of $1.62 and traded as low as $1.60. Aytu BioPharma shares last traded at $1.60, with a volume of 9,340 shares changing hands.

Aytu BioPharma Stock Performance

The firm has a market capitalization of $9.84 million, a price-to-earnings ratio of -1.30 and a beta of -1.43. The company has a current ratio of 0.99, a quick ratio of 0.80 and a debt-to-equity ratio of 0.35. The stock’s 50-day moving average is $1.62 and its 200-day moving average is $2.09.

Institutional Inflows and Outflows

A hedge fund recently raised its stake in Aytu BioPharma stock. Dimensional Fund Advisors LP raised its position in Aytu BioPharma, Inc. (NASDAQ:AYTU) by 54.5% in the 2nd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 23,551 shares of the company’s stock after purchasing an additional 8,311 shares during the quarter. Dimensional Fund Advisors LP owned 0.39% of Aytu BioPharma worth $69,000 as of its most recent SEC filing. 33.49% of the stock is currently owned by institutional investors.

About Aytu BioPharma

Aytu Biopharma, Inc is a specialty pharmaceutical company, which engages in identifying, acquiring, and commercializing novel products. It operates through the Rx and Consumer Health segments. The RX segment consists of various prescription pharmaceutical products sold through third parties. The Consumer Health segment includes various consumer health products sold directly to consumers.